Should I buy Colgate-Palmolive stock in 2025?

Why trust HelloSafe ?

At HelloSafe, our specialist has been tracking Colgate-Palmolive's stock performance for over three years. Every month, over a million users in the US trust us to analyze market trends and identify the best investment opportunities. Our analyses are written for informational purposes and do not constitute investment recommendations. In accordance with our ethical charter, we have never been, and will never be, compensated by Colgate-Palmolive.

What is Colgate-Palmolive?

The Price of Colgate-Palmolive Stock

The price of Colgate-Palmolive stock is steady this week. Currently, it trades at $92.52, showing a modest +$0.12 (+0.13%) change over the last 24 hours but down 5.09% for the week. With a market capitalization of $74.88 billion, the average 3-month daily volume is 5.53 million shares. The price/earnings ratio stands at 26.18, while the dividend yield is an attractive 2.25%, and the stock’s beta is 0.38, indicating lower volatility than the market average. This positions Colgate-Palmolive as a robust defensive choice for investors seeking stable performance and reliable income.

Our full analysis of the Colgate-Palmolive stock

After a rigorous review of Colgate-Palmolive’s recent financial results and multi-year stock performance, our analysis draws from a comprehensive mix of financial indicators, technical market signals, peer data, and qualitative assessments. Using proprietary analytical models to synthesize this information, we seek to illuminate the drivers and potential of this established consumer staples leader. So, why might Colgate-Palmolive stock once again become a strategic entry point into the defensive household products sector in 2025?

Recent performance and market context

Colgate-Palmolive’s stock is trading at $92.52 as of July 2025, reflecting disciplined strength in a challenging global environment. Over the last week, the stock has experienced a slight correction of -5.09%, aligning with rotation trends seen in the broader consumer staples sector, yet its six-month and one-year tracks remain positive and resilient. Notably, the company boasts a robust $74.88 billion market cap, supported by a healthy daily trading volume of 5.53 million shares—placing it among the most liquid defensive plays on the NYSE. Recent leadership changes, including the appointment of Shane Grant as COO, highlight Colgate-Palmolive’s commitment to operational excellence and innovation at the executive level. Meanwhile, the exit from the private label sector, scheduled for Q3 2025, further sharpens its focus on core branded segments. These developments are unfolding in an environment of steady US consumer demand and heightened attention to household essentials, amplifying Colgate-Palmolive’s strategic appeal.

Technical analysis

The technical outlook for Colgate-Palmolive is notably constructive. The 14-day RSI at 59.88 signals a balanced, neutral momentum—neither overbought nor oversold. The MACD at +0.83 provides a positive buy signal, and recent price action has kept the stock above all critical moving averages: 20-day ($90.01), 50-day ($90.85), 100-day ($89.60), and 200-day ($90.56). These alignments show that buyers are controlling the narrative, with the $91.91 support acting as a solid floor and resistance at $92.96 within striking distance, indicating a strong potential for a bullish reversal. Furthermore, the uptrend above short-term averages suggests a favorable short- and medium-term positioning for new entries, as the stock’s technical structure is providing clear signals of renewed market interest.

Fundamental analysis

Colgate-Palmolive continues to deliver a robust fundamental profile, cemented by long-term brand equity and impressive global reach. In Q1 2025, the company reported revenue of $4.91 billion—a slight YoY decrease, but nonetheless, it managed organic growth of 1.4% and an EBITDA of $1.08 billion (up 3% YoY). This translated to an adjusted EPS of $0.91, exceeding consensus by $0.05 and reaffirming management’s ability to deliver against market expectations. With a P/E Ratio of 26.18, Colgate-Palmolive is valued moderately for a defensive giant—justified by its history of reliable dividend payments (current yield: 2.25%) and enduring cash flow generation. The company’s market position is unparalleled: commanding a 40.9% share in global toothpaste and 31.9% share in toothbrushes, while its pet nutrition segment (Hill’s) is delivering organic growth of 2.9%. Colgate-Palmolive’s commitment to R&D, strong innovation pipelines, and recognized brand portfolio provides exceptional resilience through market cycles and positions the company to harness future growth opportunities.

Volume and liquidity

The liquidity story around Colgate-Palmolive is a hallmark of stability. With more than 800 million shares outstanding and a public float almost as large, market participants enjoy deep order books and efficient price discovery. The 5.53 million average daily volume (3 months) signals significant institutional attention and continuous investor engagement. Such consistent, high-volume activity makes it easier for investors of all sizes to enter and exit positions, while also minimizing bid-ask spreads during volatile periods. This dynamic adds an extra layer of security, often absent in less-followed names, and underpins the stock’s ongoing attractiveness to both long- and short-term holders.

Catalysts and positive outlook

• Ongoing innovation in personal and home care products, expanding global markets, and differentiated technology in oral care.
• Planned exit from non-core private label activities, sharpening focus on higher-margin branded offerings.
• Increasing scale in pet nutrition, reinforcing double-digit organic growth post-2023 and diversifying earnings mix.
• Leadership changes (Shane Grant as COO) injecting fresh energy and expertise to execution.
• Strong operational adaptation to adverse tariff and FX environments, with strategic flexibility to navigate future macro shocks.
• ESG focus and sustainable manufacturing initiatives, aligning with investor preferences and regulatory trends.

As a defensive stock, Colgate-Palmolive is also uniquely positioned to benefit if global macro uncertainty or volatile equity environments persist. Its broad portfolio, pricing power, and reliable customer base bolster its potential as a safe haven and a secular growth story.

Investment strategies

• Short-term: The recent dip toward technical support ($91.91) may represent an appealing entry, especially as the stock shows upward momentum above key moving averages and offers quick reversals in technical setups.
• Medium-term: Investors can target anticipated upside from operational enhancements (private label exit, leadership restructuring) and bullish consensus price targets ($98.31), positioning ahead of expected quarterly catalysts like earnings or dividend announcements.
• Long-term: For those pursuing durable accumulation, Colgate-Palmolive’s defensive sector, global brand leadership, proven innovation capabilities, and commitment to returning capital (2.25% yield, growing dividends) make it an anchor holding. Aging demographics, global middle class expansion, and rising pet health trends should support earnings growth over multiple cycles.

Positioning at or near technical lows, as well as scaling in before upcoming product launches or financial disclosures, could be especially strategic given the current technical posture and fundamental strength of the company.

Is it the right time to buy Colgate-Palmolive?

In summary, Colgate-Palmolive’s blend of world-class brands, resilient revenue, operational discipline, and sustained dividend growth seems to represent an excellent opportunity for investors seeking both stability and upside in today’s evolving market. The fundamentals more than justify renewed interest, as the company pivots from recent operational headwinds toward enhanced growth and profitability. Supported by constructive technical signals, high liquidity, and robust defensive market positioning, the stock may be entering a new bullish phase.

Colgate-Palmolive stands out as a core portfolio holding in the consumer staples sector, thanks to a unique mix of reliability, innovation, and active shareholder returns. The current setup invites serious consideration for new or expanded positions, as the combination of strong underlying trends and defensive attributes present a compelling case for upside. With technical levels at $91.91 as key support and $98–$120 as potential medium-term targets, Colgate-Palmolive may soon reward those who prioritize both quality and growth in their investment approach.

How to Buy Colgate-Palmolive Stock in the US

Buying Colgate-Palmolive stock online is simple and secure with any regulated US broker. Investors can choose to buy the stock outright for direct ownership (spot buying) or trade using Contracts for Difference (CFDs) for leveraged exposure. Both options are easily accessible through digital platforms and only require a few steps to get started. To find the best option for your needs, you’ll find a broker comparison further down the page.

Spot buying

A cash purchase of Colgate-Palmolive stock means you directly own the shares in your brokerage account. US brokers typically charge a fixed commission per order, often around $5.

Gain scenario

If the Colgate-Palmolive share price is $92.52, you can buy around 10 shares with a $1,000 stake, including a brokerage fee of around $5.

If the share price rises by 10%, your shares are now worth $1,100.

Result: +$100 gross gain, i.e. +10% on your investment.

This method is ideal for long-term investors seeking dividends and direct participation in company growth.

Trading via CFD

CFD trading on Colgate-Palmolive allows you to speculate on price movements without owning the shares. CFDs work with leverage, meaning you can control a larger position with less capital, but you’ll pay the spread and, for overnight positions, financing fees.

Example of a CFD Gain Scenario with Leverage

You open a CFD position on Colgate-Palmolive shares, with 5x leverage. This gives you a market exposure of $5,000.

✔️ Gain scenario: If the stock rises by 8%, your position gains 8% × 5 = 40%. Result: +$400 gain, on a bet of $1,000 (excluding fees).

CFDs are best suited for active traders who want to amplify their exposure and act on short-term opportunities.

Final advice

Carefully compare brokers’ fees and terms before making a decision, as costs and features can vary. The best method for buying Colgate-Palmolive stock depends on your personal objectives, risk profile, and investment horizon. You’ll find a full broker comparison further down the page to help you choose the platform that fits you best.

Our 7 tips for buying Colgate-Palmolive stock

The latest news about Colgate-Palmolive

Colgate-Palmolive shares maintained a strong technical outlook, trading above all major moving averages this week. The stock closed at $92.52, and technical indicators such as the 20-day, 50-day, 100-day, and 200-day moving averages all generated buy signals, reflecting persistent positive momentum for US-based investors.

Colgate-Palmolive delivered first-quarter results above analyst expectations for adjusted earnings per share. The company reported Q1 2025 adjusted EPS of $0.91, beating consensus by $0.05. This performance highlights Colgate-Palmolive’s resilience and ability to generate shareholder value even in challenging market conditions.

The dividend yield remained attractive, supported by a new quarterly payment and continued payout stability. Colgate-Palmolive confirmed a quarterly dividend of $0.52 per share with an annualized yield of 2.25%. The upcoming ex-dividend date is July 18, 2025, reinforcing the company’s long-term appeal for US income-focused investors.

The recent appointment of Shane Grant as Chief Operating Officer reflects Colgate-Palmolive’s commitment to growth and leadership. This leadership enhancement is expected to drive operational efficiency and strategic execution, supporting continued US-centered innovation across its iconic consumer brands.

Organic growth segments, especially in pet nutrition and oral care, continued to show positive momentum. Hill’s Pet Nutrition posted 2.9% organic growth, and the company’s leading US market share in oral care underscores its ongoing capacity to capture domestic consumer demand.

FAQ

P. Laurore

Finance expert

Co-founder of HelloSafe and holder of a Master's degree in finance, Pauline has recognised expertise in personal finance, which she uses to help users better understand and optimise their financial choices. At HelloSafe, Pauline plays a key role in designing clear, educational content on savings, investments and personal finance. Passionate about financial education, Pauline strives, with every piece of content she oversees, to provide reliable, transparent and unbiased information for independent and informed financial management. To this end, she has tested over 100 trading platforms to help internet users make the right choices.